Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Market Cap	16.93B
Revenue (ttm)	3.73B
Net Income (ttm)	142.97M
Shares Out	23.39M
EPS (ttm)	6.11
PE Ratio	118.52
Forward PE	43.87
Dividend	2.00 (0.28%)
Ex-Dividend Date	Sep 6, 2024

Volume	13,595
Average Volume	33,569
Open	730.60
Previous Close	719.80
Day's Range	721.55 - 735.50
52-Week Range	621.00 - 1,283.70
Beta	0.04
RSI	52.53
Earnings Date	May 2, 2025

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical and agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. The company serves automotive, refinery, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1996
• Employees: 689
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TATVA

Financial Performance

In 2023, Tatva Chintan Pharma Chem's revenue was 3.94 billion, a decrease of -7.11% compared to the previous year's 4.24 billion. Earnings were 303.54 million, a decrease of -33.27%.